Resonance Specialties Limited Announces Trading Window Closure Ahead of Q3 FY26 Results

Resonance Specialties Limited has announced the temporary closure of its trading window for company insiders ahead of its third quarter financial results for FY26. The Mumbai-based chemicals company made this disclosure to BSE Limited on December 22, 2025, in compliance with regulatory requirements.

Trading Window Closure Details

The company has implemented a trading window closure that will affect all designated insiders as defined under SEBI regulations. The key parameters of this closure are outlined below:

Parameter:	Details
Effective Date:	December 31, 2025 (close of business)
Duration:	Until 48 hours after Q3 results declaration
Applicable Period:	Q3 ended December 31, 2025, FY 2025-26
Regulatory Framework:	SEBI (Prohibition of Insider Trading) Regulations, 2015

Regulatory Compliance Framework

The trading window closure is mandated under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This regulatory measure ensures that company insiders cannot trade in the company's securities during periods when they may have access to unpublished price-sensitive information. The closure applies to all individuals classified as insiders under the SEBI regulations, including directors, key managerial personnel, and other designated persons who have access to material information.

Board Meeting and Results Timeline

Resonance Specialties Limited has indicated that the specific date for the Board meeting to consider the unaudited financial results for the third quarter will be communicated to the stock exchange separately. The company follows standard practice of announcing Board meeting dates in advance, allowing stakeholders to prepare for the results announcement. The trading window will reopen 48 hours after the official declaration of the quarterly financial results.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.64%	-1.19%	+8.96%	-10.85%	+4.86%	-11.58%

Financial Highlights

The company's unaudited financial results for Q2 and H1 FY2025-26 reveal impressive year-on-year growth:

Particulars (Rs. in Lakhs)	Q2 FY2025-26	Q2 FY2024-25	YoY Change	H1 FY2025-26	H1 FY2024-25	YoY Change
Revenue from Operations	2,153.35	1,806.45	19.20%	4,280.77	3,536.67	21.04%
Total Income	2,188.84	1,839.60	18.98%	4,338.97	3,595.07	20.69%
Net Profit	165.70	110.36	50.14%	328.74	221.81	48.21%
EPS (Basic & Diluted) (Rs.)	1.44	0.96	50.00%	2.85	1.92	48.44%

Key Performance Indicators

Revenue Growth: The company's revenue from operations in Q2 FY2025-26 increased by 19.20% to Rs. 2,153.35 lakhs, up from Rs. 1,806.45 lakhs in the same quarter of the previous year.
Profit Surge: Net profit for Q2 FY2025-26 saw a substantial rise of 50.14%, reaching Rs. 165.70 lakhs compared to Rs. 110.36 lakhs in Q2 FY2024-25.
Half-Year Performance: For H1 FY2025-26, total income grew by 20.69% to Rs. 4,338.97 lakhs, while net profit increased by 48.21% to Rs. 328.74 lakhs.
Earnings Per Share: The company's EPS for H1 FY2025-26 improved to Rs. 2.85, up from Rs. 1.92 in the corresponding period of the previous year.

Segment-wise Revenue

Resonance Specialties operates primarily in the chemical manufacturing segment. The company's geographical revenue distribution for H1 FY2025-26 is as follows:

Segment	Revenue (Rs. in Lakhs)	% of Total Revenue
Domestic Sales	2,005.94	46.86%
Export Sales	2,274.83	53.14%
Total	4,280.77	100.00%

The company's strong export performance, accounting for over 53% of total revenue, indicates its competitive position in international markets.

Balance Sheet Highlights

As of September 30, 2025, Resonance Specialties reported:

Total assets of Rs. 8,122.78 lakhs
A robust equity position with total equity of Rs. 6,612.22 lakhs

Conclusion

Resonance Specialties Limited has demonstrated strong financial performance in Q2 and H1 FY2025-26, with substantial growth in revenue and profitability. The company's ability to increase its export sales and maintain a healthy balance sheet position indicates its resilience and potential for sustained growth in the chemical manufacturing sector.

Investors and stakeholders may find these results encouraging, as they reflect the company's ability to capitalize on market opportunities and maintain operational efficiency in a competitive industry landscape.